12 Health Care Stocks Moving In Friday's Intraday Session
Shuttle Pharmaceuticals Holdings Inc SHPH
$3.80
▲ +22.98%
(+$0.71)
⬆️ Above Yest. High
🎈 Low Float
🗓️ Earnings Next Week
Open
$3.03
Prev Close
$3.09
Day Range
$2.92 – $4.40
52W Range
$2.58 – $55.90
Market Cap
$2.42M
Beta
1.23
EPS (TTM)
$-5.71
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-08-31 |
| Shares Out. | 640,000 |
| Website | shuttlepharma.com/ ↗ |
| Phone | 12404034212 |
| Employees | 2 |
| Net Income | -$2.2M |
| Total Assets | $11.8M |
| Total Liabilities | $8.5M |
| Equity | $3.3M |
About Shuttle Pharmaceuticals Holdings Inc
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
Shuttle Pharmaceuticals Holdings Inc is a publicly traded company under the ticker symbol SHPH on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.